New Chairman of Supervisory Board at Carl Zeiss AG
Dr. Dieter Kurz elected with immediate effect
14-05-2012: The Carl Zeiss AG Supervisory Board has elected Dr. Dieter Kurz as the new Chairman of the Supervisory Board, effective immediately.
Born in 1948, Dr. Dieter Kurz studied physics at the University of Tübingen, from which he also received his doctorate. He joined Carl Zeiss in 1979. After holding several responsible positions in research and development, marketing and sales, including a two-year stay in North America, he headed the Semiconductor Optics division and Semiconductor Manufacturing Technology busi- ness group. In 1999 he became a Member of the Executive Board and was appointed President and CEO in 2001. After the two Foundation enterprises had been transformed into stock corporations (AG) and the appropriate amendments to the Foundation's constitution had come into effect, he was President and CEO of Carl Zeiss AG from 2004 to the end of 2010.
Kurz is also Chairman of the Shareholder Council of the Carl Zeiss Foundation, Heidenheim and Jena, which is the sole shareholder of Carl Zeiss AG. He succeeds Dr. Theo Spettmann who held these offices from February 2010 and who stepped down for health reasons at the beginning of March 2012.
Contact / Request information
Request further information free of charge:
- 1Thermo Fisher Scientific to Acquire Life Technologies Corporation
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3analytica Vietnam 2013 – Platform for innovations
- 4Inspecting water quality with Raman spectroscopy
- 5LIMS/LIS Market and POCT Supplement
- 6X-ray analysis could boost legumes, thus reducing fertilizer pollution
- 7Abbott Completes Acquisition of Advanced Medical Optics
- 8MDS Sciex Opens Manufacturing Facility in Singapore
- 9Troubling levels of toxic metals found in lipstick
- 10Analytik Jena announces forecast for financial year 2012/2013
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- ZEISS presents half-year financial figures
- Analytik Jena to develop products for sepsis diagnostics
- Analytik Jena AG establishes subsidiary in Thailand





